Serves as senior domain and market strategy expert for genomics and related market areas, translating current and future market trends, applications, competitive intelligence, customer needs, and industry dynamics across RNA-seq, DNA-seq, and broader sequencing technologies into clear strategic priorities, including opportunities to move NGS technologies from basic research into translational and clinical research applications. Collaborates with R&D Director(s), commercial leaders, and cross-functional teams to define and prioritize strategic product roadmaps aligned with market opportunity, corporate goals, resource availability, and long-range portfolio needs for the genomics portfolio, with particular focus on RNA-seq, DNA-seq, and related sequencing workflows.